Skip to content

DRMA

Dermata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.83
−3.31%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
7.85x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
1.18x
Price / sales
—
Price / cash flow
-0.51x

Enterprise value

Enterprise value
-$292.5K
EV / sales
—
EV / EBITDA
0.03x
EV / EBIT
0.03x
Market cap
$4.1M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026